Department of Pharmacy, University of Washington, Seattle, USA.
Acad Radiol. 2011 Sep;18(9):1109-14. doi: 10.1016/j.acra.2011.04.007. Epub 2011 Jun 23.
Innovation in the field of diagnostic imaging is based primarily on the availability of new and improved equipment that opens the door for new clinical applications. Payments for these imaging procedures are subject to complex Medicare price control schemes, affecting incentives for appropriate use and innovation. Achieving a "dynamically efficient" health care system-one that elicits a socially optimal amount of innovation-requires that innovators be rewarded in relation to the value they add and can demonstrate with evidence. The authors examine how and whether value-based reimbursement for diagnostic imaging services might better reward innovation explicitly for expected improvements in health and economic outcomes.
诊断成像领域的创新主要基于新的和改进的设备的可用性,这些设备为新的临床应用开辟了道路。这些成像程序的支付受复杂的医疗保险价格控制计划的影响,这影响了适当使用和创新的激励。实现一个“充满活力的高效”医疗保健系统——一个引发社会期望的创新量的系统——需要根据创新者所增加的价值以及他们能够用证据证明的价值来奖励他们。作者研究了基于价值的诊断成像服务报销是否可以更好地明确奖励那些预期能改善健康和经济结果的创新。